Skip to content

All Research Preprints

Home Browse Preprints
81-100 of 579 ARTICLES
Previous Next
 in 
https://doi.org/10.12688/verixiv.2828.1
Research Article metrics
The mini chamber test: a novel bioassay for bioefficacy testing of chlorfenapyr treated nets used in malaria control
[version 1; peer review: 2 approved]
Amy Lewis, Rowan Jones-Brown, Gemma Harvey, Giorgio Praulins, Emma Reid, Aidi Galus Lugenge, Frank Mechan, Katherine Gleave, Rosemary Susan Lees
Peer Reviewers Kamaraju Raghavendra; James W Austin
  • Funder
  • Bill and Melinda Gates Foundation
PUBLISHED 28 Jan 2026
https://doi.org/10.12688/verixiv.2373.1
Research Article metrics
A key public health insecticide, chlorfenapyr, prevents development and transmission of malaria parasites
[version 1]
Natalie M. Portwood, Alanna R. Condren, Kevin Walz, Lilian P. Dorner, Buyuan He, Antonia L. Böhmert, Morgan McCauley, Harsha Vardhan Reddy, Rhiannon A.E. Logan, Shouxun Zhao, Susanne Stutz, David Malone, Friederike-Nora Vögtle, James W. Austin, Friedrich Frischknecht, Victoria A. Ingham
Peer Reviewers Invited
  • Funders
  • Deutsches Zentrum für Infektionsforschung
  • European Research Council
  • Deutsche Forschungsgemeinschaft
  • Bill and Melinda Gates Foundation
PUBLISHED 26 Jan 2026
https://doi.org/10.12688/verixiv.2811.1
Research Article metrics
Leveraging Geographic Information Systems (GISs) to Improve Polio-vaccination Coverage in Security-Compromised Areas of Nigeria: Insights from the Reach Every Settlement (RES) Strategy
[version 1]
Chukwunonso Nwaokorie, Muyi Aina, Kenneth Macaulay, Hidayah Bello, Umar Musa, Gideon Thomas, Salawu Musa, Confidence Osuji, David Otoosakyi, Fatima Bello, Chioma Ijah, Fawziyyah Sadiq, Valentine Amasiatu, Eric Aigbogun, Uchenna Igbokwe
Peer Reviewers Invited
  • Funder
  • Bill and Melinda Gates Foundation
PUBLISHED 23 Jan 2026
https://doi.org/10.12688/verixiv.2791.1
Research Article metrics
Evaluating the delivery costs and operational context of a single-dose human papillomavirus (HPV) vaccine regimen administered to a multi-age cohort of adolescent girls in Ethiopia
[version 1]
Mercy Mvundura, Rose Slavkovsky, Belayneh Dagnew, Alemayehu Hunduma, Melkamu Ayalew, Diriba Bedada
Peer Reviewers Invited
  • Funder
  • Bill and Melinda Gates Foundation
PUBLISHED 23 Jan 2026
https://doi.org/10.12688/verixiv.2832.1
Systematic Review metrics
Regulatory Provisions for Post-Release Monitoring of Genetically Modified Organisms in Africa
[version 1]
Julia Njagi, John Muriuki, Paul Mbugua, Brinda Dass, Staphanie James, Dorington Ogoyi
Peer Reviewers Invited
  • Funder
  • Bill and Melinda Gates Foundation
PUBLISHED 23 Jan 2026
https://doi.org/10.12688/verixiv.2802.1
Systematic Review metrics
INTEGRATION OF ETHNOMEDICINE IN HEALTH AND BIOMEDICAL SCIENCE CURRICULA IN AFRICA: A SCOPING REVIEW
[version 1]
Reggies Wenyika, Tafadzwa Dzinamarira, Stanley Mukanganyama
Peer Reviewers Invited
  • Funder
  • Bill and Melinda Gates Foundation
PUBLISHED 23 Jan 2026
https://doi.org/10.12688/verixiv.2592.1
Research Article metrics
Considerations for post-release environmental safety monitoring of gene drive-modified mosquitoes as a tool for malaria control in Sub-Saharan Africa
[version 1]
Paul Abram, Jeremy Bouyer, Brinda Dass, Dorington Ogoyi, Fredros Okumu, Justin Overcash, Stephanie James
Peer Reviewers Invited
  • Funders
  • Agriculture and Agri-Food Canada
  • Bill and Melinda Gates Foundation
PUBLISHED 23 Jan 2026
https://doi.org/10.12688/verixiv.2797.1
Systematic Review metrics
A REVIEW OF BARRIERS TO THE COMMERCIALIZATION OF ETHNOMEDICINE IN ZIMBABWE: IMPLICATIONS FOR POLICY AND PRACTICE
[version 1]
Reggies Wenyika, Tafadzwa Dzinamarira
Peer Reviewers Invited
  • Funder
  • Bill and Melinda Gates Foundation
PUBLISHED 23 Jan 2026
https://doi.org/10.12688/verixiv.2815.1
Systematic Review metrics
Systematic review of the impacts of L-arginine and L-citrulline on pregnancy outcomes in animal models
[version 1]
Jonquile Williams, Kendra Tiani, Julian Amundaray, Reid Schwartz, Jaida Vicente, Judith Uyanne, Patrick Hollister, Adetutu Udofia, Margaret Foster, Amanda MacFarlane, Regan Bailey, Patrick Stover, Martha Field
Peer Reviewers Invited
  • Funder
  • Bill and Melinda Gates Foundation
PUBLISHED 23 Jan 2026
https://doi.org/10.12688/verixiv.2806.1
Research Article metrics
Identifying Climatic Risk Hotspots for the Dairy Production System of South Asia: An Integrated Analysis with Projections for 2050s and 2080s
[version 1]
Sanjit Maiti, Kaushik Bora, Siddhesh Zade, Brijesh Yadav, Sunita Sanjyal, Paresh Shirsath, Sanchita Garai, Rukhsana Amin Runa, WMPB Weerasinghe, Philip Thornton, Pramod Kumar Aggarwal
Peer Reviewers Invited
PUBLISHED 23 Jan 2026
https://doi.org/10.12688/verixiv.2810.1
Systematic Review metrics
A Century with Foot-and-Mouth Disease: Assessing the Continual Threat to African Livestock 1924 – 2024
[version 1]
Adebayo Emmanuel Sopeju, John Sotito Fadele, Anyebe Bernard Onoja, Andrew Raymond Peters, Adedayo Omotayo Faneye
Peer Reviewers Invited
  • Funder
  • Bill and Melinda Gates Foundation
PUBLISHED 23 Jan 2026
https://doi.org/10.12688/verixiv.2002.2
Research Note metrics AWAITING PEER REVIEW
Revised
Evaluation of sensitivity of the Truenat MTB Ultima/COVID-19 assay to detect SARS-CoV-2 in frozen nasopharyngeal samples
[version 2; peer review: awaiting peer review]
Nitin Chandwani, Parul Sharma, Vinzeigh Leukes, Rita Székely, Adam Penn-Nicholson, Manju Purohit
Peer Reviewers Invited
  • Funder
  • Government of Canada
LATEST VERSION PUBLISHED 21 Jan 2026
https://doi.org/10.12688/verixiv.725.2
Study Protocol metrics AWAITING PEER REVIEW
Revised
Neuroimaging Ancillary Study of the IV Iron RAPIDIRON/RAPIDIRON KIDS Trial
[version 2; peer review: awaiting peer review]
Douglas Dean, Virupaxi Hattiholi, Mahesh Kamate, Moriah Thomason, Kiran Talekar, Anmol Patted, Simal Thind, Jesse Bradford-Rogers, Danielle DeSantis, Jose Guerrero-Gonzalez, Umesh Charantimath, Manjunath Somannavar, S. Yogeshkumar, Rebecca Hartman, Benjamin Leiby, Roopa Bellad, Zubair Aghai, Michael Georgieff, Shivaprasad Goudar, Mrutyunjaya Bellad, Richard Derman
Peer Reviewers Invited
  • Funders
  • Children’s Investment Fund Foundation
  • Gates Foundation
LATEST VERSION PUBLISHED 21 Jan 2026
https://doi.org/10.12688/verixiv.2640.2
Research Article metrics
Revised
A mark and recapture perspective on vaccination touchpoints
[version 2; peer review: 2 approved with reservations]
Niket Thakkar
Peer Reviewers Dale A. Rhoda; Sumit Aggarwal
  • Funder
  • Bill and Melinda Gates Foundation
LATEST VERSION PUBLISHED 20 Jan 2026
https://doi.org/10.12688/verixiv.2788.1
Research Article metrics
Compound effector genes suppress malaria parasite infections in gene-drive population modification strains of the African malaria mosquitoes, Anopheles gambiae and Anopheles coluzzii
[version 1]
Rebeca Carballar-Lejarazú, Yuemei Dong, Thai Bihn Pham, Taylor Tushar, Mihra Tavadia, George Dimopoulos, Anthony James
Peer Reviewers Invited
  • Funders
  • University of California Irvine Malaria Initiative
  • Bill and Melinda Gates Foundation
PUBLISHED 19 Jan 2026
https://doi.org/10.12688/verixiv.2667.1
Research Article metrics
A Phase 3b Study to Evaluate the Safety, One-year Antibody Persistence, and Priming Immune Responses of Three Doses of Eupolio Inj., a New Inactivated Polio Vaccine Made from Sabin Strains, and Immunogenicity of Two Doses of Eupolio Inj. Following Three Doses of bOPV in Infants.
[version 1]
Maria Rosario Capeding, Edison Alberto, Krongporn Ongprasert, Delia Yu, Maria Nerissa De Leon, Pope Kosalaraksa, Thanyawee Puthanakit, Boonyarat Warachit, Maria Esterlita Uy, Anna Lisa T. Ong-Lim, Ilsu Kim, Jihyun Heo, Youngeun Roh, Keswadee Lapphra
Peer Reviewers Invited
  • Funder
  • Bill and Melinda Gates Foundation
PUBLISHED 19 Jan 2026
https://doi.org/10.12688/verixiv.2623.1
Research Article metrics
Lesion Viral Burden, Multidrug-resistant Superinfection and HIV-linked Haematological Vulnerability Define Triage-Relevant Risk in Acute Clade Ib Mpox in Uganda
[version 1]
Jennifer Serwanga, Raymond Ernest Kaweesa, Geoffrey Odoch, Brenda Nairuba, Deborah Mukisa, Rodney Abraham Tumusiime, Ruth Priscilla Nambi, Annie Daphine Ntabadde, Violet Ankunda, Tom Lutalo, Michael Selorm Avumegah, John Bosco Nsubuga, Christopher Nsereko, Pontiano Kaleebu
Peer Reviewers Invited
  • Funders
  • Bill and Melinda Gates Foundation
  • Coalition for Epidemic Preparedness Innovations
PUBLISHED 19 Jan 2026
https://doi.org/10.12688/verixiv.2764.1
Open Letter metrics
Rotavirus Mucosal Immunology: Insights and Research Priorities from an International Convening in Liverpool, March 2024
[version 1]
Christina Bronowski, Chikondi Mwendera, Carl Kirkwood, Duncan Steele, Michelle Groome, Khuzwayo Jere
Peer Reviewers Invited
  • Funders
  • NIHR Global Health Research Group on Gastrointestinal Infections at the University of Liverpool
  • Bill and Melinda Gates Foundation
PUBLISHED 19 Jan 2026
https://doi.org/10.12688/verixiv.2553.1
Research Article metrics
Saliva PCR Performs Comparably to Lesion Swabs for Acute-Phase Clade Ib Mpox Diagnosis in Uganda: Evidence from a Matched Hospital Cohort
[version 1]
Geoffrey Odoch, Raymond Ernest Kaweesa, Brenda Nairuba, Edward Kiyonga, Violet Ankunda, Laban Kato, Ruth Priscilla Nambi, Rodney Abraham Tumusiime, Deborah Mukisa, Solomon Opio, Joseph Katende Ssebwana, Sembera Jackson, Annie Daphine Ntabadde, John Bosco Nsubuga, Peter Ejou, Michael Selorm Avumegah, Christopher Nsereko, Pontiano Kaleebu, Jennifer Serwanga
Peer Reviewers Invited
  • Funders
  • Centralised Laboratory Network
  • Bill and Melinda Gates Foundation
PUBLISHED 19 Jan 2026
https://doi.org/10.12688/verixiv.2526.1
Case Report metrics
Case Report: Severe Clade I (subclade Ib) mpox in advanced HIV complicated by multidrug-resistant bacterial superinfection and ocular involvement: A case report from Uganda
[version 1]
Raymond Ernest Kaweesa, Brenda Nairuba, Geoffrey Odoch, Rodney Abraham Tumusiime, Deborah Mukisa, Annie Daphine Ntabadde, Violet Ankunda, Pontiano Kaleebu, Christopher Nsereko, Jennifer Serwanga
Peer Reviewers Invited
  • Funder
  • Bill and Melinda Gates Foundation
PUBLISHED 19 Jan 2026
81-100 of 579 ARTICLES
Previous Next
PUBLISH YOUR RESEARCH
Articles
SUBMIT AN ARTICLE
See how it works, guidelines and policies.

Stay Informed

Sign up for information about developments, publishing and publications from VeriXiv.

You must provide your first name
You must provide your last name
You must provide a valid email address
You must provide an institution.

Thank you!

We'll keep you updated on any major new updates to VeriXiv

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.
Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.